Abstract:Background: The American Association for the Study of Liver Diseases (AASLD) guidelines recommend that antibiotic prophylaxis should be instituted in any patient with cirrhosis and gastrointestinal hemorrhage, and that oral norfloxacin, intravenous ciprofloxacin, and ceftriaxone are preferable. However, the antimicrobial spectrum of the first generation of cephalosporins (cefazolin) covers a wide range of bacteria species, including community-acquired strains of Escherichia coli and Klebsiella pneumoniae, but their efficacy as prophylactic antibiotics in cirrhotic patients with acute hemorrhage was seldom warranted in the literature. This study aimed to explore the effects of cefazolin on the outcome of cirrhotic patients with acute variceal hemorrhage after endoscopic interventions. Methods: A cross-sectional, retrospective chart review study was conducted on cirrhotic patients with acute variceal hemorrhage who underwent endoscopic procedures in a medical center. Cirrhotic patients who did not receive antibiotics were classified as group A (n = 63) while patients who received intravenous cefazolin 1 g q8 h for 2-7 days were classified as group B (n = 50). The end points were the prevention of infection, length of hospital stay, time of rebleeding, and death. Results: A total of 113 patients were studied (male/female: 82/31; age: 56.8 ± 13.5 years). The incidence of infection (including proven infections) and bacteremia were significantly lower in group B patients (38.1% vs. 16.0%, P = 0.010; 17.5% vs. 4.0%, P = 0.026; 9.5% vs. 0%, P = 0.033, respectively). The no prophylactic antibiotics treatment was the independent risk factor. There was no significant difference between the two groups with respect to the source of bleeding, type of endoscopic intervention, length of hospital stay, and mortality. Actuarial probability of remaining free of early rebleeding (<7 days) was P = 0.105 by log-rank test for all cirrhosis patients and P = 0.085 for Child-Pugh class A patients. Conclusions: The use of cefazolin in cirrhotic patients after endoscopic interventions for acute variceal hemorrhage reduced infections. A trend of actuarial probability of remaining free of early rebleeding (<7 days) was observed, especially in Child-Pugh class A patients. This study may be hampered by the small sample size and more large-scale studies are mandatory.

The effect of prokinetic drug on intestinal origin endotoxemia in liver cirrhosis

Effect of Antibiotic Prophylaxis on Nosocomial Infection in Liver Cirrhotic Patients with Acute Upper Gastrointestinal Hemorrhage

Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis

Effect of andrographitis on intestinal bacterial overgrowth,bacterial translocation and intestinal permeability in cirrhotic rats

Cisapride Prevents Enteric Bacterial Overgrowth and Translocation by Improvement of Intestinal Motility in Rats with Acute Liver Failure

Probiotic Pre-Administration Reduces Mortality in a Mouse Model of Cecal Ligation and Puncture-Induced Sepsis.

Effect of Probiotic Treatment on Cirrhotic Patients with Minimal Hepatic Encephalopathy: A Meta-Analysis.

Intestinal Microbiota and Innate Immunity-Related Gene Alteration in Cirrhotic Rats with Liver Transplantation

Dynamic Variability of Intestinal Flora and Endotoxin in Rat with Fulminate Hepatic Failure

Effect of Probiotics on Immune Function of Patients with Cirrhosis

Effects of Lactulose on Intestinal Endotoxin and Bacterial Translocation in Cirrhotic Rats

Effect of Gut-Derived Endotoxin Change of Cytokines in Liver Diseases

Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl 4 -induced liver cirrhosis by protecting the intestinal barrier in rats

The Dose-Effect Study on Preventive Experiment of Scutellaria Decoction on Liver Cirrhosis Endotoxemia

Antioxidant protective effects of lactitol against endotoxemia in patients with chronic viral hepatitis.

The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions

Lactobacillus Reuteri DSM 17938 Alleviates D-Galactosamine-induced Liver Failure in Rats.

Effect of Baicalin and Octreotide on the Expression Levels of P‐selectin Protein in Multiple Organs of Rats with Severe Acute Pancreatitis

Effects of Lactobacillus acidophilus LB on Serum Ammonia and Plasma Endotoxin in Patients with Cirrhosis

Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial

Therapeutic effects of arotinolol,propranolol and carvedilol on portal hypertension in cirrhotic rats